NEW YORK (GenomeWeb) – GE Healthcare Life Sciences will open a new US headquarters for GE Healthcare Life Sciences in Marlborough, Mass., according to a statement released today by the firm and the Massachusetts Life Sciences Center.
The 160,000 square-foot facility is expected to open in the spring of 2015. GE said that it will invest $21 million in the site, which will house 500 GE Healthcare Life Science employees, including more than 220 new jobs. It said that the currently unoccupied space will be transformed into state-of-the-art labs, customer application facilities, and office space, and it will complement GE Healthcare Life Sciences' existing manufacturing facilities in Westborough, Mass.
The new headquarters will consolidate GE Healthcare Life Sciences' US East Coast presence and include employees from across the life sciences business, including research, bioprocessing, medical imaging, in vitro diagnostics, and services.
This is the first time that GE has established a US headquarters for the life sciences business, according to a GE spokesman, with operations previously spread among sites in New Jersey and Massachusetts. He said GE Healthcare Life Sciences' global headquarters remain in Amersham, UK.
"Our new facility in Massachusetts will position us for continued innovation and competition in such a fast-paced, innovative industry," Kieran Murphy, president and CEO of GE Healthcare Life Sciences, said in the statement. "We will be close to industry-leading talent, customers, and world-class academic and medical institutions across all the industry sectors we serve, from biotech and pharma, to diagnostics and medical devices."
GE Healthcare Life Sciences generates around $4 billion in annual revenues from the sale of research tools aimed at accelerating molecular medicine, as well as for basic research of cells and proteins, drug discovery, cell therapies, and regenerative medicine.
The Massachusetts Life Sciences Center is a $1 billion state-funded effort to support life sciences research, development, and commercialization in Massachusetts.